APA (7th ed.) Citation

J, C., H, W., C, S., Z, F., Z, S., T, C., . . . L, Z. (2026). The impact of SGLT2i on the outcome of advanced lung cancer in patients with diabetes. Frontiers in oncology, 16, 1759702. https://doi.org/10.3389/fonc.2026.1759702

Chicago Style (17th ed.) Citation

J, Chen, Wang H, Shang C, Fan Z, Sheng Z, Chu T, Zhang M, and Zhao L. "The Impact of SGLT2i on the Outcome of Advanced Lung Cancer in Patients with Diabetes." Frontiers in Oncology 16 (2026): 1759702. https://doi.org/10.3389/fonc.2026.1759702.

MLA (9th ed.) Citation

J, Chen, et al. "The Impact of SGLT2i on the Outcome of Advanced Lung Cancer in Patients with Diabetes." Frontiers in Oncology, vol. 16, 2026, p. 1759702, https://doi.org/10.3389/fonc.2026.1759702.